SUBSCRIBE
SUBSCRIBE

Nick Paul Taylor

Nick is a freelance writer who has been reporting on the global life sciences industry since 2008. With a BSc in biology, Nick writes about the science and business of biopharma and medtech for numerous healthcare publications. He can be reached at nick.paul.taylor@gmail.com or on LinkedIn.

German flags waving in the wind at famous Reichstag building, seat of the German Parliament (Deutscher Bundestag), on a sunny day with blue sky and clouds, central Berlin Mitte district, Germany.
Manufacturing
Moderna mulls deals to rescue German BioNTech plants from closure: report
The takeovers depend on Moderna reaching an agreement with the German government, which risks losing investment from drugmakers over planned healthcare reforms.
June 18, 2026
 · 
2 min read
 · 
Nick Paul Taylor
Medical capsule with Euro bank notes inside on white background
Policy
Germany rethinking drug price reforms after Lilly, Boehringer withdraw investments: Reuters
Weeks after Boehringer Ingelheim and Eli Lilly retracted billions of dollar in German commitments, the nation’s government is reportedly changing a contentious element of its planned healthcare reforms.
June 15, 2026
 · 
2 min read
 · 
Nick Paul Taylor
The house sparrow is a bird of the sparrow family Passeridae, found in most parts of the world.
Manufacturing
FDA imposes import alert on Indian plant after inspectors flag GMP failings
Officials sanctioned Dabur India months after FDA inspectors found bird droppings and data integrity deficiencies during an inspection of the plant.
June 12, 2026
 · 
2 min read
 · 
Nick Paul Taylor
Photo of pinned Columbus on a map of USA. May be used as illustration for traveling theme.
Manufacturing
Hikma outlines plan to invest $267M in Ohio plants, creating 350 jobs
The money will enable the addition of aseptic filling and oral solid dose capabilities to support Hikma’s products and contract manufacturing clients.
June 9, 2026
 · 
1 min read
 · 
Nick Paul Taylor
There is one person missing to complete the team. Recruiting workers. Workforce gaps, job recruitment, and staffing needs. Job vacancy. Talent acquisition campaigns to fill essential roles.
FDA
Busy FDA gives rare disease sector complementary pathways, unanswered questions
The FDA has expanded the regulatory toolkit during President Donald Trump’s second term, adding new mechanisms for rare diseases while putting the Biden-era platform technology designation into action.
June 8, 2026
 · 
8 min read
 · 
Nick Paul Taylor
USA, EU and Greenland on the map of North Atlantic Ocean in soft grunge and vintage style, like old paper with watercolor painting.
Manufacturing
Lilly and Boehringer roll back billions in German investments over health budget cuts
With Germany moving to curb healthcare spending, Eli Lilly and Boehringer Ingelheim have rethought plans to invest in facilities, including a manufacturing plant for GLP-1 drugs.
June 4, 2026
 · 
2 min read
 · 
Nick Paul Taylor
Medication Warning: Yellow Caution Sign with Scattered Capsules
Manufacturing
FDA hits Medline with warning letter over long-running contamination problem
FDA inspectors found that Medline, which raised billions of dollars last year, failed to prevent repeat bacterial contamination of finished drug products.
June 3, 2026
 · 
2 min read
 · 
Nick Paul Taylor
concept of rising drug prices
Manufacturing
Pharma manufacturing projected to create 19,000 jobs through 2034
The forecast makes pharma one of the fastest-growing manufacturing industries in the U.S.
June 3, 2026
 · 
2 min read
 · 
Nick Paul Taylor
Illustration of two arrows merging into one
Manufacturing
CordenPharma inks AmbioPharm buyout to continue peptide production expansion
Swiss service provider CordenPharma is acquiring AmbioPharm, gaining facilities such as a plant in South Carolina to provide a fully U.S.-based supply.
June 1, 2026
 · 
2 min read
 · 
Nick Paul Taylor
Vector Illustration Healthy Lungs Gradient Colorful Style.
Lung cancer
ASCO: Kelun-Merck ADC shines with differentiated overall survival in first-line lung cancer
Interim overall survival data on a TROP2 ADC from Merck and Chinese partner Kelun-Biotech provide support for the pharma’s big bet on its potential to help navigate Keytruda’s impending loss of exclusivity.
June 1, 2026
 · 
2 min read
 · 
Nick Paul Taylor
Laptop with envelope and document with exclamation mark on screen. Receive notification, alert message, warning, get e-mail, email, spam concepts. Flat design vector illustration
Manufacturing
Cracked gaskets and rust-like residues trigger FDA warning letter to Alchymars
FDA inspectors found Alchymars failed to adequately maintain equipment used to make active pharmaceutical ingredients for the U.S. market. Over-the-counter drugmakers GC America and Sato Pharmaceutical also received warning letters.
May 29, 2026
 · 
2 min read
 · 
Nick Paul Taylor
Active construction site with cranes, workers, builders and skyscrapers under development. Process of building. Vector illustration. Line art style. Isometric view of a monolithic frame building.
Manufacturing
Niowave, fresh from Novartis deal, starts building $75M radioisotope plant
Having secured deals with AstraZeneca and Novartis, Niowave is constructing a second facility to meet rising demand for actinium-225, which can be used to develop next-generation radiopharmaceuticals.
May 26, 2026
 · 
2 min read
 · 
Nick Paul Taylor
High Quality background with Two Flags of South Korea and USA
Manufacturing
Gilead inks $140M API supply deal, tightening ties to Korean manufacturer
The agreement is the largest in a series of deals that Gilead Sciences has penned with Korea’s Yuhan.
May 22, 2026
 · 
1 min read
 · 
Nick Paul Taylor
too many different pill of various blisters with different pills Medicines storage at home concept Medication storing. A pile of medicine in blister packs. Pharmaceutical blister packs.
Manufacturing
Roche licensing pact clears generic drugmakers to manufacture antiviral flu drug
By partnering with a UN-backed body, Roche has enabled companies to make the medicine for supply in 129 countries.
May 21, 2026
 · 
2 min read
 · 
Nick Paul Taylor
Email envelope with warning sign on white background
Manufacturing
FDA sends warning letter after Chinese supplier breaks GLP-1 import restrictions
While the manufacturer is on the list of authorized GLP-1 importers, FDA inspectors found the company relabeled APIs from another site in a potential attempt to “circumvent safeguards.”
May 20, 2026
 · 
2 min read
 · 
Nick Paul Taylor
Load More